Sign in
4

Changes in Ownership

aTYR PHARMA INC Filed Acc 0001209191-16-094242

Options or other derivatives

  • VP, Clinical Affairs acquired 18,250 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Blackburn Kelly VP, Clinical Affairs 2016-01-27 Grant or award · Employee Stock Option (right to buy) +18,250 18,250 D: show line 1 in the form
Loading xslF345X03/doc4.xml…